Belmar Pharmacy
503A Compounding Pharmacy — FDA safety data from public records
On This Page
Colorado-based 503A compounding pharmacy focused on patient-specific prescriptions across hormone therapy, peptides, and weight-management compounds including GLP-1 formulations.
Website: belmarpharmacy.com
Data last verified: 2026-04-25
Company Snapshot
Entity Type
503A Compounding Pharmacy
FDA Registration
Not shown
Warning Letters
0
Recalls
0
States Licensed
Not listed
Compounding Status
503A
What This Company Profile Actually Tells You
Belmar Pharmacy is categorized here as a 503A compounding pharmacy. That places it in a patient-specific compounding framework rather than the broader outsourcing-facility model used by many 503A operations.
Belmar Pharmacy's exact geographic footprint is not summarized on this page, so readers should confirm state availability before assuming access in their market. For a 503A pharmacy, the practical due-diligence questions are whether prescriptions are patient-specific, which states the pharmacy serves, how sterile products are handled, and whether the pharmacy has been associated with warning letters, recalls, or repeated quality concerns.
That makes this page less like a generic company overview and more like a risk-screening document. Users comparing 503A pharmacies want to know what the pharmacy is allowed to do, how transparent it is, and whether the public record shows issues they should investigate before filling a prescription.
Belmar Pharmacy Background
Market Position
Belmar is better known as a specialty compounding pharmacy than as a consumer-facing weight-loss brand. Patients usually encounter the name through a provider referral or fulfillment discussion.
Business Model
As a 503A pharmacy, Belmar operates in the patient-specific prescription lane rather than the broader outsourcing-facility framework used by 503B operators. That changes how consumers should interpret its legal role and production model.
Pharmacy And Supply Notes
Belmar matters when patients want to know exactly which pharmacy is compounding a custom prescription. In that setting, the key questions concern state licensure, sterile process controls where relevant, and how patient-specific compounding is documented.
Consumer Risk Notes
A 503A label does not make a pharmacy risky by default, but it should push readers to confirm that the exact prescription flow is compliant, individualized, and transparent.
Key Facts
Belmar is a patient-specific compounding pharmacy rather than a mass-market telehealth platform.
Its relevance to GLP-1 consumers usually comes through prescription fulfillment rather than front-end marketing.
Patients should verify how the provider-pharmacy relationship works and whether the prescription is truly individualized.
Risk Summary
No FDA warning letters are currently shown in this profile.
No recall events are currently shown in the FDA enforcement data surfaced here.
No direct FDA establishment registration record is displayed on this page.
Compounding status is listed as 503A.
Regulatory And Compliance Analysis
Registration Context
We do not currently show direct FDA registration data for Belmar Pharmacy. For a pharmacy profile, that usually means readers should verify both the legal business name and the specific facility role before assuming the company lacks registration.
Warning Letter Readout
We did not find FDA warning letters for Belmar Pharmacy in this profile. That is better than the alternative, but it is not a blanket endorsement. A clean warning-letter record only tells you that this page is not currently surfacing a published FDA warning letter tied to the entity.
Recall Readout
No recall events are shown for Belmar Pharmacy here. For consumers, that lowers one category of concern, but it still does not replace verification of sourcing, labeling, temperature handling, and pharmacy quality controls.
Adverse Event Context
This profile does not currently show a meaningful adverse-event dataset for Belmar Pharmacy. In practice, that usually means readers should lean more heavily on registration, recalls, warning letters, and pharmacy-partner transparency when evaluating risk.
FDA Registration
No direct FDA establishment registration record is shown in this profile for Belmar Pharmacy. For telehealth companies, that is often expected because the brand may coordinate care while external pharmacies or outsourcing facilities handle compounding or dispensing. Readers should verify the underlying pharmacy partner rather than relying on the consumer brand alone.
FDA Warning Letters (0)
No FDA warning letters are currently shown for Belmar Pharmacy in this profile. That is helpful context, but users should still verify current marketing claims, pharmacy sourcing, and how the company describes compounded medications.
Recall History (0)
No recalls are currently displayed for Belmar Pharmacy in the openFDA enforcement data surfaced on this page. That lowers one obvious risk signal, but it should not be treated as proof that all products, batches, or fulfillment practices are problem-free.
Source: openFDA Drug Enforcement API
Adverse Event Reports
This profile does not currently show a meaningful adverse-event summary for Belmar Pharmacy. When that dataset is absent, readers should lean more on the documented public record around registration, recalls, warning letters, and pharmacy-partner transparency.
Source: FDA Adverse Event Reporting System (FAERS). Adverse event reports do not establish causation.
Questions Patients Should Ask Before Using Belmar Pharmacy
Can Belmar Pharmacy confirm the exact facility name, operating status, and whether the prescription will be filled under a 503A or 503B framework?
What does Belmar Pharmacy tell patients about compounded versus FDA-approved products, and does that language avoid implying equivalence or approval where it does not exist?
How does Belmar Pharmacy handle dose escalations, refill delays, refunds, cancellations, and temperature-sensitive shipping problems?
If a patient has a side effect or receives a product-quality concern, what is the human escalation path and how quickly does Belmar Pharmacy respond?
Can Belmar Pharmacy provide lot-level documentation, pharmacy details, and a clear explanation of what safety checks happen before medication is dispensed?
Similar Companies
These related profiles are useful for searchers comparing Belmar Pharmacy against adjacent providers or pharmacies. Reading similar pages side by side usually reveals whether a concern is unique to one company or common across this category.
How To Use This Profile
This profile organizes public-source safety signals for Belmar Pharmacy, including FDA registration status, warning letters, recalls, and any adverse event summary data available in the dataset.
A company can appear relatively clean here and still deserve more diligence, because absence of a warning letter or recall is not the same as proof of quality.
For 503a compounding pharmacy pages especially, readers should distinguish between the consumer-facing brand and the pharmacy or facility that actually handles medication production or dispensing.
Looking for a Verified GLP-1 Provider?
FormBlends partners with licensed 503A compounding pharmacies. Every compound is third-party tested with certificates of analysis.
Learn MoreDisclaimer: This page aggregates publicly available data from the FDA, state pharmacy boards, and other government sources. It is provided for informational purposes only and does not constitute medical or legal advice. FDA registration does not imply FDA approval or endorsement. The absence of warning letters or recalls does not guarantee safety or quality. Always consult your healthcare provider before making decisions about medications. Data may not reflect the most current status. Last updated: 2026-04-25.
Safety Guides
503A vs 503B pharmacies
Understanding the FDA oversight difference.
How to read a Certificate of Analysis
What every CoA should include and red flags to watch for.
What FDA registration actually means
Registration vs approval: the distinction most people miss.
Choosing a compounding pharmacy
What to verify before you fill your first prescription.
GLP-1 Safety Alerts
Get notified when the FDA issues warning letters, recalls, or regulatory updates affecting GLP-1 medications and compounding pharmacies.
Free. No spam. Unsubscribe anytime.
Frequently Asked Questions
Is Belmar Pharmacy FDA registered?
We do not currently have FDA registration data for Belmar Pharmacy. This may mean the company operates under a different entity name or is regulated at the state level.
Has Belmar Pharmacy received any FDA warning letters?
We have not found any FDA warning letters issued to Belmar Pharmacy in our records. This page is updated regularly as new FDA data becomes available.
Does Belmar Pharmacy have any recalls?
We have not found any recalls associated with Belmar Pharmacy in the openFDA enforcement database.
Is Belmar Pharmacy a telehealth company or a pharmacy?
Belmar Pharmacy is categorized in this profile as a 503a compounding pharmacy. That distinction matters because a telehealth brand, a 503A pharmacy, and a 503B outsourcing facility operate under different regulatory expectations.
Does a clean profile mean Belmar Pharmacy is definitely safe?
No. A clean profile means we are not currently surfacing certain FDA signals like warning letters or recalls for Belmar Pharmacy. It does not guarantee product quality, customer-service quality, or future regulatory compliance.
What should patients verify before using Belmar Pharmacy?
Patients should verify who is prescribing, which pharmacy or outsourcing facility is actually fulfilling the medication, what the company says about compounded versus FDA-approved products, and how billing, cancellations, and side-effect escalation are handled.